Florida Senate - 2023                        COMMITTEE AMENDMENT
       Bill No. CS for SB 1506
       
       
       
       
       
       
                                Ì6061485Î606148                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                   Comm: WD            .                                
                  04/20/2023           .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Rules (Rodriguez) recommended the following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Between lines 1283 and 1284
    4  insert:
    5         Section 18. Present subsections (6) through (11) of section
    6  465.1895, Florida Statutes, are redesignated as subsections (7)
    7  through (12), respectively, a new subsection (6) is added to
    8  that section, and subsection (1) and paragraph (b) of subsection
    9  (5) of that section are amended, to read:
   10         465.1895 Testing or screening for and treatment of minor,
   11  nonchronic health conditions.—
   12         (1) A pharmacist may test or screen for and treat minor,
   13  nonchronic health conditions within the framework of an
   14  established written protocol with a supervising physician
   15  licensed under chapter 458 or chapter 459 or a standard protocol
   16  adopted in rule by the board in consultation with the Board of
   17  Medicine and the Board of Osteopathic Medicine. For purposes of
   18  this section, a minor, nonchronic health condition is typically
   19  a short-term condition that is generally managed with minimal
   20  treatment or self-care, and includes:
   21         (a) Influenza.
   22         (b) Streptococcus.
   23         (c) Lice.
   24         (d) Skin conditions, such as ringworm and athlete’s foot.
   25         (e) Minor, uncomplicated infections.
   26         (5) The written protocol between a pharmacist and
   27  supervising physician under this subsection must include
   28  particular terms and conditions imposed by the supervising
   29  physician relating to the testing and screening for and
   30  treatment of minor, nonchronic health conditions under this
   31  section. The terms and conditions must be appropriate to the
   32  pharmacist’s training. A pharmacist who enters into such a
   33  protocol with a supervising physician must submit the protocol
   34  to the board.
   35         (b) A pharmacist authorized to test and screen for and
   36  treat minor, nonchronic conditions under a supervising physician
   37  protocol shall provide evidence of current certification by the
   38  board to the supervising physician. A supervising physician
   39  shall review the pharmacist’s actions in accordance with the
   40  protocol.
   41         (6) In lieu of entering into a protocol with a supervising
   42  physician under subsection (5), a pharmacist may test or screen
   43  for and treat minor, nonchronic health conditions under a
   44  standard protocol adopted in rule by the board in consultation
   45  with the Board of Medicine and the Board of Osteopathic
   46  Medicine. A pharmacist testing or screening for and treating
   47  minor, nonchronic health conditions under the standard protocol
   48  must submit a signed copy of the standard protocol to the board.
   49  At a minimum, the standard protocol shall include:
   50         (a) Specific categories of patients whom the pharmacist is
   51  authorized to test or screen for and treat minor, nonchronic
   52  health conditions.
   53         (b) Instructions for obtaining relevant patient medical
   54  history for the purpose of identifying disqualifying health
   55  conditions, adverse reactions, and contraindications to the
   56  approved course of treatment.
   57         (c) Instructions for the treatment of minor, nonchronic
   58  health conditions based on the patient’s age, symptoms, and test
   59  results, including negative results.
   60         (d) Any other requirements as established by the board in
   61  consultation with the Board of Medicine and the Board of
   62  Osteopathic Medicine.
   63  
   64  ================= T I T L E  A M E N D M E N T ================
   65  And the title is amended as follows:
   66         Delete line 72
   67  and insert:
   68         examination; amending s. 465.1895, F.S.; authorizing
   69         pharmacists to test or screen for and treat minor,
   70         nonchronic health conditions under a standard protocol
   71         adopted by the Board of Pharmacy in consultation with
   72         the Board of Medicine and the Board of Osteopathic
   73         Medicine, in lieu of entering into a protocol with a
   74         supervising physician; requiring such pharmacists to
   75         submit a signed copy of the standard protocol to the
   76         board; providing minimum requirements for the standard
   77         protocol; amending s. 468.1115, F.S.; providing